https://www.dukehealth.org/clinical-trials/directory/pro00114544
EvoPAR-Prostate01: AZD5305 vs... | Clinical Trials at Duke
Clinical Trial NCT: NCT06120491 at Duke Health is recruiting patients. View the details of this clinical trial to learn more about participating.
clinical trialsvsduke
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2024-08484&r=1
Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus...
Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/...